Niklas Kouparanis, Co-Founder & CEO of Bloomwell Group

Professionally Cannabis and Psychedelics

English - May 26, 2022 14:00 - 30 minutes - 19.5 MB - ★★★★★ - 4 ratings
Alternative Health Health & Fitness Medicine cannabis weed marijuana business investing pot potstocks cannabiz psychedelics psychedelic Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ben Lightburn, Co-Founder & CEO, Filament Health

Next Episode: Tim Schlidt, Co-Founder and Partner at Psychedelics VC Firm, Palo Santo

For this week’s episode, we talk cannabis in Germany with Niklas Kouparanis, the Co-Founder & CEO of Bloomwell Group.

With the biggest medical cannabis market in Europe and imminent plans to pass new laws permitting recreational use of the plant, Nik joins us to discuss the practicalities, time lines and critical success factors for Germany, as adult-use cannabis in the country has moved from an ‘if’ to a ‘when’.

Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/